Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ TMEM254 Recombinant Protein Antigen
SDP

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Supplier:  Novus Biologicals™ NBP258228PEP

Catalog No. NBP258228PE


Explore available promotions
Add to Cart

Description

Description

A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human C10orf57. Source: E.coli Amino Acid Sequence: QSIPYQNLGPLGPFTQYLVDHHHTLLCNGYWLAWLIHVGESLYAIVLCKHKGITSGR The TMEM254 Recombinant Protein Antigen is derived from E. coli. The TMEM254 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.
Specifications

Specifications

80195
C10orf57 Recombinant Protein Antigen
PBS and 1M Urea, pH 7.4.
bA369J21.6, chromosome 10 open reading frame 57, FLJ13263, RP11-369J21.6, transmembrane protein C10orf57
Unlabeled
100μL
E.Coli
>80% by SDS-PAGE and Coomassie blue staining
Store at −20C. Avoid freeze-thaw cycles.
Blocking/Neutralizing, Control
TMEM254
Recombinant Protein Antigen
RUO
This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-51163. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.

For Research Use Only